| Neuland Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524558 |
NSE Symbol : NEULANDLAB |
P/E(TTM) : 50.35 |
|
ISIN Demat : INE794A01010 |
Div & Yield% : 0.11 |
EPS(TTM) : 249.53 |
|
Book Value(₹) : 994.26 |
Market Cap(₹Cr) : 16,120.50 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 439.60 | 385.01 | 392.83 | 417.75 | 362.99 | 407.07 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 439.60 | 385.01 | 392.83 | 417.75 | 362.99 | 407.07 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 25.43 | 5.36 | 2.10 | 3.05 | 2.04 | 8.06 |
| Total Income | 465.03 | 390.37 | 394.93 | 420.80 | 365.03 | 415.14 |
| Total Expenditure | 315.78 | 278.22 | 272.26 | 280.45 | 265.73 | 287.36 |
| PBIDT | 149.26 | 112.15 | 122.67 | 140.35 | 99.30 | 127.78 |
| Interest | 2.67 | 3.61 | 3.74 | 4.43 | 2.21 | 4.29 |
| PBDT | 146.59 | 108.54 | 118.92 | 135.91 | 97.09 | 123.49 |
| Depreciation | 16.28 | 16.46 | 15.14 | 14.51 | 13.59 | 13.47 |
| Tax | 30.58 | 21.92 | 25.28 | 31.44 | 20.95 | 25.34 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.39 | 2.55 | -2.20 | 0.90 | 0.33 | 0.18 |
| Reported Profit After Tax | 98.34 | 67.61 | 80.70 | 89.06 | 62.22 | 84.51 |
| Extra-ordinary Items | 15.57 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 82.77 | 67.61 | 80.70 | 89.06 | 62.22 | 84.51 |
| EPS (Unit Curr.) | 76.65 | 52.70 | 62.90 | 69.42 | 48.50 | 65.87 |
| EPS (Adj) (Unit Curr.) | 76.65 | 52.70 | 62.90 | 69.42 | 48.50 | 65.87 |
| Calculated EPS (Unit Curr.) | 76.23 | 52.41 | 62.56 | 69.04 | 48.23 | 65.51 |
| Calculated EPS (Adj) (Unit Curr.) | 76.23 | 52.41 | 62.56 | 69.04 | 48.23 | 65.51 |
| Calculated EPS (Ann.) (Unit Curr.) | 304.92 | 209.63 | 250.23 | 276.16 | 192.93 | 262.04 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 304.92 | 209.63 | 250.23 | 276.16 | 192.93 | 262.04 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 33.95 | 29.13 | 31.23 | 33.60 | 27.36 | 31.39 |
| PBDTM(%) | 33.35 | 28.19 | 30.27 | 32.53 | 26.75 | 30.34 |
| PATM(%) | 22.37 | 17.56 | 20.54 | 21.32 | 17.14 | 20.76 |